System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Ahead of print

PubMed: 42765370 DOI: 10.1177/19475535261486946

From Archetypes to Access: A Two-Axis Governance Framework and Decision-Support Tool for Rare Specimen Biobanking.

Biopreserv Biobank

Authors: E Paul Lerner, Michael J Kim, Thomas D Walters, Eytan Wine, Hien Q Huynh, Troy Perry

Affiliations

  • Division of General Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.
  • Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Department of Pediatrics and Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Division of Pediatric GI Nutrition, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
  • Division of Pediatric Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.

Abstract

INTRODUCTION

Biobanks fulfill their scientific and ethical mandates when collected specimens are used effectively. Access policies govern researcher eligibility, allocation, oversight, and intellectual property (IP) considerations. Despite their importance, access policies vary substantially and lack a unifying practical framework.

OBJECTIVES

We sought to identify commonalities and areas of under-specification across access policies in surgically oriented, pediatric, and/or national biobanks to describe real-world practices and develop a typology of rare biospecimen governance.

METHODS

We conducted a targeted scoping review of access policies from 32 biobanks identified from the Biobank Resource Centre Biobank Locator, with 19 providing sufficient governance information (59% response). Responses were coded using 10 domains researcher eligibility, oversight, allocation rules, data/sample coupling, industry access, fees, reporting, authorship, unused sample handling, and IP. Descriptive statistics and comparative analysis were used to identify patterned co-variation. A large language model (ChatGPT and OpenAI) was used to organize coded attributes and generate potential governance typologies, which were refined and verified by the authors.

RESULTS

Governance attributes clustered along two conceptually distinct dimensions Access Orientation (facilitative vs. stewardship-oriented) and Allocation Logic (procedurally neutral vs. strategically prioritized). Their interaction produced four corresponding governance archetypes: Academic Commons, Rare Specimen Stewardship, Investigator-Led Facilitation, and Protected National Strategic Asset. Unused sample handling and IP were the most frequently under-specified domains. No novel structural configurations emerged after 13 cases.

CONCLUSION

Access policy variations reflect coherent governance orientations that reveal differing institutional priorities and conceptions of the biobank's role in research facilitation and stewardship. By articulating two analytic axes and four archetypes, we provide a practical framework for interpreting policy differences across biobanks and identifying areas of under-specification. New and evolving biobanks can use this typology to align policies with their mission, scarcity constraints, and ethical obligations, supporting transparent decision-making and responsible and effective use of research specimens.

MeSH

Research